PhRMA Moves To Vanquish FTC Rule Targeting Drugmakers
The Pharmaceutical Research and Manufacturers of America on Friday urged a D.C. federal judge to vacate a Federal Trade Commission rule requiring pharmaceutical companies to report more exclusive patent licenses for...To view the full article, register now.
Already a subscriber? Click here to view full article